학술논문
Real-World Evidence of Ribociclib Plus Aromatase Inhibitors as First-Line Treatment in Advanced Breast Cancer: The BrasiLEEira Study
Document Type
Article
Author
Source
In: JCO Global Oncology . (JCO Global Oncology, 2024, 10)
Subject
Language
English
ISSN
26878941